Connect with us

General News

COVID19 – China Expects a Developed Vaccine by November 2020

Published

on

The increasing number of infected cases and COVID-19 deaths have led to nothing but fear and chaos worldwide. Governments are trying to control their respective nations and enforcing drastic safety measures, with nearly 6 million cases. All of this led to a global lockdown and economic crisis.

The outbreak particularly began in Wuhan, at the start of 2020, and infected enough individuals, to cause the start of strict actions in March, worldwide. With the flattening of the curve in some parts of the world, governments are uplifting the lockdown. However, the situation is still not under control.

Many researchers worldwide have been working on a vaccine or a cure for the coronavirus. Clinical trials are conducted for potential drugs as well. This led to researches on older drugs such as BCG or previously used drugs for similar illnesses such as Remdesivir. The U.S approved the anti-viral drug Remdesivir for the start of trials as it recovered 50% of the patients. 30% of the other half, faced significant recovery, if not complete.

During this entire time, the health care industry is an integral element. While health care workers are constantly risking their lives to save patients, researchers are constantly working on the cure and vaccine. The Chinese government, however, has declared a Chinese COVID-19 vaccine. They expect the vaccine to be ready by the end of the year.

The vaccine

Two companies are currently working on the vaccine. The Chinese states own them as well as the Assets Supervision and Administration Commission (SASAC) who made a post on social media on Friday. They have stated that it is possible to release it by the end of 2020, or early 2021.

The two companies are the Wuhan Institute of Biological Products and the Beijing Institue of Biological Products. Reuters has reported that the 2 companies have begun the second phase of testing for their developed vaccines. Furthermore, they have completed the administration of doses to over 2,000 individuals during clinical trials.

The SASAC has reported about the production line of the Beijing Institute of Biological Products. It is said that the production can be anywhere between 100 million and 200 million vaccine shots in a 1-year period, at its full capability. furthermore, the Chinese researchers have 5 ongoing immunization tests, conducted on humans. This is currently greater in comparison to any other nation worldwide.

China is believed to be the origin of the deadly virus. This is mainly because he first infected case and outbreak began in Wuhan, China. However, the country exists with its own medical organizations, regulators, study groups, and other private companies. Each of them is on the mission to develop the first coronavirus vaccine. Consequently, there is an effort to team up, despite the overtime work hours.

Chinese President has vowed to share the success of any vaccine, with other countries. However, Bloomberg has reported the past issues of China with production quality and security disrepute.

Other vaccines and clinical trials

Vaccine

Deccan Herald

Earlier estimations had pointed towards the duration of another year. However, the Chinese who expect a vaccine by the end of 2020, says otherwise. Director of the National Institute of Allergy and Infectious Diseases, Anthony Fauci gave a statement regarding the potential vaccine. He stated that they could develop the vaccine by November after the FDA provides clearance for clinical vaccine trials.

Meanwhile, the Department of Health and Human Services has signed contracts. The contracts require the delivery of $100 million value of syringes. This will all lead to the vaccination drive. The World Health Organization has stated that over 100 potential COVID-19 vaccines are currently being tested. They are undergoing preclinical trials while 10 of those vaccines will be approved for human testing this week.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

General News

Minnesota Cannabis Legalization Bill All Set For Approval

Published

on

cannabis legalization

The cannabis legalization bill has been represented in different states, including Minnesota. The House of Minnesota has been having discussions regarding the subject. After considering every aspect of the bill, the House will soon pass and implement it.

Cannabis legalization and decriminalization bills in different states aim to enhance the flourishing of the marijuana industry. Other objectives include providing equal opportunity to people of color and minorities to start their businesses. Possession of a certain amount will not lead to imprisonment as possessing marijuana up to a certain amount for individuals above 21 will be legal.

The Efforts Of Minnesota Legislature For Passing The Bill

Legislatures have been trying for many years to formulate and pass a bill allowing recreational or adult use of marijuana. On Thursday, the Minnesota House will vote regarding approving the legislation. If the cannabis legalization bill gets approval on Thursday, then people in Minnesota above the age of twenty-one can easily use marijuana for recreational purposes.

DFL leaders to legalize marijuana have been making efforts and presenting bills. But there has been a delay in passing these bills due to the opposition of Republicans. According to Rep. Winkler, the opposition does not want to vote and is not interested in passing the cannabis legalization bill in any way. Winkler further adds that opposition is the main reason for delaying legalization and decriminalization of cannabis.

According to state DFL leaders, every detail about the cannabis legalization bill has been discussed. The topic of discussion includes the possible outcome of passing the bill and the benefits it will generate for Minnesota. Leaders are highly hopeful that the bill will get approval during a House meeting scheduled for Thursday at 4:30 p.m.

Why Republicans Oppose Cannabis Legalization Bill in Minnesota

Republicans highlight that they intend to manage the budget without increasing taxation. Paul Gazelka is the Republican Senate Majority Leader. According to Paul, improving the economy by safely reopening schools and business activities is better than legalizing cannabis for people.

Besides, Republicans have doubts and concerns regarding the side effects of the recreational use of marijuana. Republicans elaborate their perspective by saying that adverse effects to recreational use of cannabis have appeared in some areas. Thus, according to them, it is better to learn more before passing the cannabis legalization bill in Minnesota.

But Rep. Winkler disagrees with the Republican point of view. According to Paal Carter, the tobacco and alcohol industries are working effectively within regulations, and the cannabis industry will work likewise by following cannabis legalization and decriminalization bills.

Winkler clarifies that the formulation of the cannabis legalization bill represented in the House took over two years. After completing research, talking to law enforcement, and considering public health officials’ opinions and concerns, the bill formulation occurs. Thus, there is nothing to worry about, and the bill is all set to pass.

Possible Changes That Can Occur After Approval of Cannabis Legalization Bill 

The passing of this bill will enable the legal business and sales of cannabis products. The cannabis legalization bill will result in anyone above the age of 21 purchasing cannabis for recreational purposes from an authorized marijuana retailer. Record-keeping regarding cannabis users and the demand or sales of cannabis products will be easy.

After passing and putting the marijuana legalization bill into action, Minnesota will be able to earn large tax revenues. Other states that legalized marijuana last year were able to obtain huge tax revenue. According to the Tax Foundation, Colorado and Washington successfully earned more than $300 million through tax revenue from legal cannabis activities.

Twelve of the House committees have approved of cannabis legalization, and the final decision will occur on Thursday after the vote.

Continue Reading

Cannabis

Marijuana Cultivation in Colombia by Flora Growth Becomes Public

Published

on

marijuana cultivation

Marijuana cultivation within any state has to be per the cannabis laws of that state. In Colombia, some cannabis cultivators can grow cannabis outside within a certain area.

There are chances of the introduction of new cannabis reforms at the federal level. Investors are making their moves while observing the situation closely as their profit or loss depends upon new regulations. Marijuana cultivation usually takes place in indoor greenhouses. In Canada, mostly cannabis companies cultivate marijuana through the controlled environment in greenhouses.

Some cannabis companies have their set up in Canada and different states of the United States. Production units can be found in Canada and the US, and the types of methods used for cannabis cultivation can vary.

Marijuana Cultivation Methods and Cultivation Preferences 

Cannabis cultivation can occur inside greenhouses and outside in an open environment if temperature and other growth factors are appropriate for its growth. Moreover, marijuana cultivation in the outside or open fields is cost-effective and requires traditional methods for this process of cultivation.

Indoor greenhouse cultivation of cannabis occurs in a controlled environment, and it yields the best marijuana product qualitatively and quantitatively. Latest technologies are used in this method of cultivation. The cost for marijuana cultivation using new technologies is much greater than the cost-spends at its growth using traditional methods.

Some growth tricks used to increase the yield of cannabis include topping, super cropping, flushing, low-stress training, and monster chopping. Other cutting methods can increase the growth of marijuana.

ALSO READ: Canopy Growth And Other Cannabis Company Stocks Rise

Flora Growth is a cannabis company in Colombia, USA, and has headquarters in Toronto, Canada. The company cultivates marijuana for producing its medicinal products via traditional methods.

In Colombia, cannabis companies do not quickly get a license to register and grow marijuana within companies’ premises. According to CEO Luis Merchan, Flora Growth has the approval of the Colombian government for legal marijuana cultivation, and cultivating a gram of marijuana dry flowers costs only 6 cents. The cost of indoor cultivation of cannabis in North America is about $1.25.

Despite being cost-effective, companies are not racing to get Colombian government approval as these companies prefer cultivating marijuana closer to home.

Alterations in Flora Growth Shares 

Investors are not interested in investing in Flora Growth, and company shares continue to fall up to four percent, reported CNN. Traditional marijuana cultivation costs remarkably low, and Flora Growth can generate high-quality cannabis-based foods. Flora Growth also formulates beauty products using cannabis.

The increase in share prices is slow, and the company is still small as compared to other companies involved in the cannabis business on an international level. Flora Growth has to make many efforts to improve its share price and grow to become a bigger cannabis company like Altria, Tilray, and Canopy.

Flora Growth has made a public offering to make mergers or sign contracts with other companies and investors. The CEO is confident that Flora Growth will successfully increase its share prices. The company can earn sufficient earnings by selling good quality products produced at low cost as it uses traditional marijuana cultivation methods.

ALSO READ: Marijuana Business Legislation Will Alter in New Jersey

The company has a partnership with Miss Universe of 2014, Paulina Vega. As a result of this partnership, the launch of Flora Growth cannabis-infused topical products has become easy and effective in increasing stock prices. The skincare cannabis product formulation occurs by extracting CBD and other non-psychoactive phytochemicals from the cannabis plant. The extraction of components occurs by utilizing plants grown through traditional marijuana cultivation methods.

According to Merchan, Flora Growth has remarkable cultivation facilities, infrastructure, marketing team, cooperative working team, and efficient sales team across the globe.

Changes in reforms to marijuana cultivation, sales, possession, and other marijuana activities will increase competition, and Flora Growth has the potential to flourish in a highly competing environment.

Continue Reading

Cannabis

What Cause Biden To Change his Policies For Cannabis?

Published

on

Biden

Ever since Biden took office as president, reforms have been under discussion for formulating new cannabis regulations and legislation at both the federal and state levels. After the election, people and investors were hopeful that the cannabis industry would flourish and progress in multiple markets as the government introduces new cannabis legislation.

Members of Biden’s political party have put forward bills recommending decriminalization and legalization of weed at activities at the state level, reports Forbes. Some states have already legalized and decriminalized marijuana business activities. Others are still discussing and making amendments to formulate effective cannabis regulations.

Democrats, of which Biden is a member, promised to decriminalize marijuana and introduce new cannabis regulations. Everyone had the impression that the Biden administration would legalize and decriminalize marijuana without any delay. However, more than five months of the New Year have passed, and there is no change in federal cannabis legislation. The drug is still under the controlled substance list and remains 100 percent illicit on the federal level.

People and investors are beginning to doubt the Biden administration’s approach towards cannabis regulations. Some are immensely disappointed with the philosophical approach of authorities towards marijuana legislation.

Five Members of Biden Administration Got Fired, People Have Their Concerns 

The reason for firing five of the members from the Biden administration is not clear. But it is likely to be associated with their past cannabis use. New cannabis regulations suggest allowing individuals to apply for various jobs or continue a job even if they have used marijuana at any time in their life. However, such legislation has not yet been passed on the federal level.

Firing employees because of their past cannabis habits is not fair. Everyone at least once in their life has used marijuana intentionally or unintentionally. Even president Joe Biden has admitted to using marijuana in his past life. There was a time when the FBI did not hire people with past cannabis use. But the FBI changed its cannabis regulations more than a decade ago and permitted people who no longer use marijuana to apply for jobs in the FBI.

ALSO READ: Legalizing Cannabis Generates Jobs In Various States, Says Survey Reports

The change in FBI cannabis regulations does not occur over a day. Changes occur over the years and deep debates on national and international levels. Eventually, permission to apply for a job in the FBI requires that as long as you pass the drug test and are not using drugs anymore. Moreover, the FBI has made amendments over the years. The White House shall also consider making new cannabis regulations.

People find this unacceptable and are disappointed in the authorities as they have forced five individuals to leave office because of their past marijuana usage.

The MORE Act

The MORE Act is not yet practiced but is under process. The Marijuana Opportunity Reinvestment and Expungement Act will introduce great cannabis regulations. According to the MORE Act, it is better to remove marijuana from the list of controlled drugs.

Furthermore, it suggests that people who have overcome their habit of cannabis use shall not suffer bullying in society. They shall be given equal rights as any other citizen has. The White House passed this bill. In August 2020, a bill suggesting allowing people to continue their lives without being charged for cannabis use in the past.

ALSO READ: Medical Marijuana Use is Now a Crime in Indonesia

Such a bill was in favor of legalizing and decriminalizing marijuana. Does Biden’s perspective on renewing cannabis regulations get affected because of his son’s condition relating to substance use? If so, the president and his administration shall reconsider the cannabis legislation for legalizing and decriminalizing marijuana.

The cannabis industry has great potential and a margin for enhancement or making progress. It will help to generate huge revenue and improve the economy. Biden favors state-level legalization of marijuana. He shall make new cannabis regulations for the federal level too.

Continue Reading

Trending

error: Content is protected !!